354 related articles for article (PubMed ID: 25689283)
1. Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.
Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
J Cell Mol Med; 2015 Jun; 19(6):1346-56. PubMed ID: 25689283
[TBL] [Abstract][Full Text] [Related]
2. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis.
Lin C; von der Thüsen J; Daalhuisen J; ten Brink M; Crestani B; van der Poll T; Borensztajn K; Spek CA
Mol Med; 2015 Jun; 21(1):576-83. PubMed ID: 26147947
[TBL] [Abstract][Full Text] [Related]
4. Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.
Lin C; Rezaee F; Waasdorp M; Shi K; van der Poll T; Borensztajn K; Spek CA
Oncotarget; 2015 Nov; 6(34):35304-14. PubMed ID: 26474459
[TBL] [Abstract][Full Text] [Related]
5. Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2.
Kalayarasan S; Sriram N; Soumyakrishnan S; Sudhandiran G
Toxicol Appl Pharmacol; 2013 Sep; 271(2):184-95. PubMed ID: 23656969
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.
Borensztajn K; Bresser P; van der Loos C; Bot I; van den Blink B; den Bakker MA; Daalhuisen J; Groot AP; Peppelenbosch MP; von der Thüsen JH; Spek CA
Am J Pathol; 2010 Dec; 177(6):2753-64. PubMed ID: 20971733
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
[TBL] [Abstract][Full Text] [Related]
9. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.
Zhang G; Kernan KA; Collins SJ; Cai X; López-Guisa JM; Degen JL; Shvil Y; Eddy AA
J Am Soc Nephrol; 2007 Mar; 18(3):846-59. PubMed ID: 17267741
[TBL] [Abstract][Full Text] [Related]
10. Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.
Duitman J; Ruela-de-Sousa RR; Shi K; de Boer OJ; Borensztajn KS; Florquin S; Peppelenbosch MP; Spek CA
Mol Med; 2014 Sep; 20(1):410-6. PubMed ID: 24842054
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.
Mercer PF; Johns RH; Scotton CJ; Krupiczojc MA; Königshoff M; Howell DC; McAnulty RJ; Das A; Thorley AJ; Tetley TD; Eickelberg O; Chambers RC
Am J Respir Crit Care Med; 2009 Mar; 179(5):414-25. PubMed ID: 19060230
[TBL] [Abstract][Full Text] [Related]
12. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
Howell DC; Johns RH; Lasky JA; Shan B; Scotton CJ; Laurent GJ; Chambers RC
Am J Pathol; 2005 May; 166(5):1353-65. PubMed ID: 15855637
[TBL] [Abstract][Full Text] [Related]
13. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
14. High endogenous activated protein C levels attenuates bleomycin-induced pulmonary fibrosis.
Lin C; von der Thüsen J; Isermann B; Weiler H; van der Poll T; Borensztajn K; Spek CA
J Cell Mol Med; 2016 Nov; 20(11):2029-2035. PubMed ID: 27295971
[TBL] [Abstract][Full Text] [Related]
15. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis.
Howell DC; Laurent GJ; Chambers RC
Biochem Soc Trans; 2002 Apr; 30(2):211-6. PubMed ID: 12023853
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2.
Sokolova E; Grishina Z; Bühling F; Welte T; Reiser G
Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L793-802. PubMed ID: 15563688
[TBL] [Abstract][Full Text] [Related]
17. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
18. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
